RDGLOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
VIVOS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.05−0.00 (-2.51%)
Close on Oct 19, 2026
- Market cap
- $23.44M
- P/E (TTM)
- –
- Dividend yield
- –
VIVOS INC revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IsoPet [Member] | $81.80K | $70.98K | $133.67K | $0 | $9.36K | – | – | – | – | – | 224.7% | +773.9% |
| Service [Member] | $2.50K | – | – | – | – | – | – | – | – | – | 6.9% | – |
| Freight [Member] | $2.10K | $2.10K | $175 | $175 | $700 | – | – | – | – | – | 5.8% | +200.0% |
| Polymer [Member] | $0 | $3.17K | $352 | $704 | – | – | – | – | – | – | 0.0% | – |
| Discount - IsoPet [Member] | -$50.00K | -$40.18K | – | $0 | -$4.36K | – | – | – | – | – | -137.3% | +1046.7% |
| Discount - Services [Member] | – | – | $0 | -$2.15K | -$10.23K | -$59.44K | $0 | $0 | $0 | -$2.00K | – | – |
| Services - Treatments [Member] | – | – | $0 | $3.15K | $19.53K | $66.20K | $5.00K | $5.00K | $13.50K | $6.50K | – | – |
| Discount - Certifications [Member] | – | – | $0 | $0 | $0 | -$10.00K | – | – | – | – | – | – |
| Certification [Member] | – | – | $7.50K | $0 | $0 | $29.98K | – | – | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of Vivos's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.